AzTrials
AzTrials

Enteral FeedingNCT04464057

Safety and Effectiveness of Early Feeding After Bowel Anastomosis in Neonates or Infants

A study testing early oral feeding or early enteral nurtrion in people with Enteral Feeding and Neonate, run by Weibing Tang at 2 sites in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The study is primary designed to evaluate the safety and effectiveness of early feeding after bowel anastomosis, and observe the effect of early postoperative feeding on promoting postoperative rehabilitation and reducing parenteral nutrition Read more about this study

Who is it for?
Ages 1 day to 12 months
Conditions the study is for
Enteral Feeding, Neonate, Infant
What is being tested?
early oral feeding or early enteral nurtrion
Type of treatment
Pill or oral medicine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
947 participants
Where
2 sitesChina
Study dates
1 Aug 2020to 31 Aug 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 day to 12 months
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • (1)neonates or infants less than 12 months (2)Intestinal anastomosis, including small intestine and colon anastomosis

Who cannot join

  • (1) Premature infants or children with a weight of less than 2.5 kg during surgery are excluded (2) Exclude cases of severe abdominal infection (3) Exclude cases of severe imbalance of the proximal and distal intestinal canal of the anastomosis (such as intestinal atresia)

Trial locations and contacts

2 sites in 1 country.

China2 sites
  • Anhui Provincial Children's Hispital

    Hefei, Anhui

  • Xuzhou CHildren's Hospital Affilated to Xuzhou Medical College

    Xuzhou, Jiangsu, 210000

Other trials in China

About this study

The study is primary designed to evaluate the safety and effectiveness of early feeding after bowel anastomosis, and observe the effect of early postoperative feeding on promoting postoperative rehabilitation and reducing parenteral nutrition

Read the detailed description

Intestinal anastomosis is a common operation for the treatment of digestive tract diseases of newborns and infants. It is not be defined that when should begin oral feeding after intestinal anastomosis. Poor anastomotic healing or anastomotic leakage is the most serious complication after intestinal anastomosis, which often leads to severe abdominal infection, peritonitis and even death. Nowadays, it is believed that the causes of poor anastomotic healing or anastomotic leakage are various, including contaminated during the operation, the blood supplyment of the bowel edges at both ends of the anastomosis, anemia, anastomosis technique, type of surgery (selective or emergency), and anastomotic tension . The traditional view is that early feeding may increase the anastomotic tension, which may lead to poor anastomotic healing or leakage, so a lot of surgeons often take a fasting for 4-5 days after intestinal anastomosis to ensure good anastomotic healing, however there is no enough evidence for this view. On the contrary, the current research confirms that after intestinal anastomosis, under fasting conditions, the digestive system still has 1-2 liters of fluid through the anastomosis, so even if it is given postoperative oral feeding, It would not excessively increase the digestive fluid through the anastomosis. Obviously, the early guess that the anastomotic tension is increased is lacking in theoretical evidence. In recent years, with the in-depth study of intestinal function, intestinal mucosal barrier function and intestinal flora, early enteral nutrition has stretched more and more attention, which is believed could stimulate intestinal digestive fluid secretion, promote intestinal mucosal metabolism and repair, avoid intestinal villi atrophy, reduce intestinal bacterial translocation, promote intestinal function recovery and intestinal peristalsis. Postoperative intestinal obstruction is also an important reason for hindering early enteral nutrition, but current research believes that postoperative intestinal obstruction is often temporary, and in most cases will be relieved 4-8 hours after surgery. European Society of Parenteral Enteral Nutrition (ESPEN ) recommended that enteral nutrition should be performed within 24 hours after intestinal anastomosis, but it needs to be fully evaluated according to the children's own tolerance and the type of surgery. A large number of studies and meta-analysis have confirmed that early enteral nutrition is safe and feasible after intestinal anastomosis in adults, but there are still few studies in children, especially whether early enteral surgery can be performed after intestinal anastomosis is currently rarely reported in neonates and infants. This study evaluated the feasibility and effectiveness of early oral enteral nutrition in neonates and infants after intestinal anastomosis through a prospective study.

Being tested
early oral feeding or early enteral nurtrion
Keywords
oral feeding, early enteral nurtrion, Intestinal anastomosis, neonate, infant

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • early oral feeding or early enteral nurtrionDietary supplement

    The patients in the experimental group were fed orally within 24-48 hours after intestinal anastomosis. Start taking it at 24-48 hours after surgery until discharged. The initial dose is 1ml/kg.h, which is gradually increased to 100ml/kg daily.

Study groups in NCT04464057
Study groupRoleWhat they receive
experimental groupExperimentalThe patients in the experimental group would be given early oral feeding within 24-48 hours after intestinal anastomosis. Start taking it at 24-48 hours after surgery until discharged. The initial dose is 1ml/kg.h, which is gradually increased to 100ml/kg daily.
Receives: Dietary Supplement: early oral feeding or early enteral nurtrion
control groupNo interventionThe control group would be given early oral feeding within 4-5 days after intestinal anastomosis. Start taking it at 4-5 days after surgery until discharged. The initial dose is 1ml/kg.h, which is gradually increased to 100ml/kg daily.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Anastomotic leakage or poor anastomotic healing

    Feces flow out from the site of the anastomosis into the abdominal cavity

    Measured: 1-7days after early oral feeding

  2. Gastrointestinal symptoms:nausea, vomiting, diarrhea, abdominal pain and abdominal distent.

    There may be some unexpected symptoms happen after early oral feeding after anastomosis such as Nausea, vomiting, diarrhea, abdominal pain and abdominal distent.

    Measured: 1-14days after early oral feeding

  3. indexs of stress:C-reactive protein, interleukin 6, cortisol

    Some indexs could be defined as indicators of the severity of the stress response

    Measured: The first day and third day after early oral feeding

  4. indexs of nurtrion:weight, serum albiumin,serum prealbumin and serum retinol binding protein

    Some indexs could be defined as indicators of the nutriton status

    Measured: The seventh day after anastomosis

Secondary outcomes (1)
  1. indexs of recovery after surgery:Time to first bowel movement, time to use intravenous nutrition and total postoperative hospital stay

    Some indexs could be defined as indicators of recovery after surgery.

    Measured: 1-14 days after surgery.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Jul 2020
  2. Study start1 Aug 2020
  3. Primary completion1 Aug 2022
  4. Study completion31 Aug 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
The study is a prospective, randomized controlled clinical study. A total of 285 inpatients (95 experimental groups and 190 control groups) were enrolled to evaluate the safety and effectiveness of early feeding in neonates and infants after intestinal anastomosis
Masking
Single blind
Who is masked
Participant
Enrolment
947 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04464057
Sponsor's protocol ID
NanjingCH
Status last verified
Dec 2022
First submitted
6 Jul 2020
Last updated
13 Dec 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: The data of the study would be shared with othe researchers.

Publications

  • Lu C, Sun X, Geng Q, Tang W. Early oral feeding following intestinal anastomosis surgery in infants: a multicenter real world study. Front Nutr. 2023 Jul 20;10:1185876. doi: 10.3389/fnut.2023.1185876. eCollection 2023.

    PubMed 37545580

Questions about this trial

What is this clinical trial studying?

A study testing early oral feeding or early enteral nurtrion in people with Enteral Feeding and Neonate, run by Weibing Tang at 2 sites in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Dec 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Anastomotic leakage or poor anastomotic healing (time frame: 1-7days after early oral feeding). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04464057, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Dec 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in